-
Dr. Pasi Janne talks about a new lung cancer study at ASCO 2012
-
1:09
-
Pasi Jänne, MD, PhD, Dana-Farber Cancer Institute, talks about a new study being presented at ASCO 2012 involving a clinical trial that shows the success of targeted therapies in one of the most common forms of lung cancers. The results could mean a treatment or place to start for treatment concerning this type of lung cancer.
Tags: LungCancer, TargetedTherapy